Hangzhou Push-Kang Biotechnology

Hangzhou Push-Kang Biotechnology is a high-tech medical enterprise specializing in the development of advanced In Vitro Diagnostic (IVD) systems based on centrifugal microfluidic technology. The company provides a comprehensive "instrument + reagent + chip" solution designed for Point-of-Care Testing (POCT) in both human and veterinary medicine. Their product portfolio includes automated analyzers and disposable microfluidic chips that cover clinical chemistry, immunology, coagulation, and molecular diagnostics. By integrating complex laboratory procedures into a single, automated chip, Push-Kang enables rapid and accurate testing in decentralized settings such as emergency rooms and clinics. The company is a leader in the domestic Chinese microfluidics market and is expanding its global footprint.